China · Delayed Price · Currency is CNY Hangzhou Biotest Biotech Statistics
Total Valuation
SHA:688767 has a market cap or net worth of CNY 6.23 billion. The enterprise value is 4.83 billion.
| Market Cap | 6.23B |
| Enterprise Value | 4.83B |
Important Dates
The last earnings date was Saturday, April 25, 2026.
| Earnings Date | Apr 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688767 has 146.32 million shares outstanding. The number of shares has decreased by -1.60% in one year.
| Current Share Class | 146.32M |
| Shares Outstanding | 146.32M |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | +42.43% |
| Owned by Insiders (%) | 24.63% |
| Owned by Institutions (%) | 9.49% |
| Float | 56.56M |
Valuation Ratios
The trailing PE ratio is 203.49.
| PE Ratio | 203.49 |
| Forward PE | n/a |
| PS Ratio | 13.85 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 102.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 79.89, with an EV/FCF ratio of -59.22.
| EV / Earnings | 159.28 |
| EV / Sales | 10.74 |
| EV / EBITDA | 79.89 |
| EV / EBIT | 136.33 |
| EV / FCF | -59.22 |
Financial Position
The company has a current ratio of 14.11, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.11 |
| Quick Ratio | 13.33 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.21% and return on invested capital (ROIC) is 3.84%.
| Return on Equity (ROE) | 1.21% |
| Return on Assets (ROA) | 0.88% |
| Return on Invested Capital (ROIC) | 3.84% |
| Return on Capital Employed (ROCE) | 1.49% |
| Weighted Average Cost of Capital (WACC) | 7.96% |
| Revenue Per Employee | 745,443 |
| Profits Per Employee | 50,270 |
| Employee Count | 622 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 3.29 |
Taxes
| Income Tax | -3.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.31% in the last 52 weeks. The beta is 0.67, so SHA:688767's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +39.31% |
| 50-Day Moving Average | 35.18 |
| 200-Day Moving Average | 38.63 |
| Relative Strength Index (RSI) | 69.68 |
| Average Volume (20 Days) | 2,690,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688767 had revenue of CNY 449.50 million and earned 30.31 million in profits. Earnings per share was 0.21.
| Revenue | 449.50M |
| Gross Profit | 208.15M |
| Operating Income | 35.42M |
| Pretax Income | 25.79M |
| Net Income | 30.31M |
| EBITDA | 60.44M |
| EBIT | 35.42M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 1.40 billion in cash and 435,359 in debt, with a net cash position of 1.40 billion or 9.59 per share.
| Cash & Cash Equivalents | 1.40B |
| Total Debt | 435,359 |
| Net Cash | 1.40B |
| Net Cash Per Share | 9.59 |
| Equity (Book Value) | 2.36B |
| Book Value Per Share | 16.19 |
| Working Capital | 1.47B |
Cash Flow
In the last 12 months, operating cash flow was 60.91 million and capital expenditures -142.44 million, giving a free cash flow of -81.53 million.
| Operating Cash Flow | 60.91M |
| Capital Expenditures | -142.44M |
| Depreciation & Amortization | 25.02M |
| Net Borrowing | n/a |
| Free Cash Flow | -81.53M |
| FCF Per Share | -0.56 |
Margins
Gross margin is 46.31%, with operating and profit margins of 7.88% and 6.74%.
| Gross Margin | 46.31% |
| Operating Margin | 7.88% |
| Pretax Margin | 5.74% |
| Profit Margin | 6.74% |
| EBITDA Margin | 13.45% |
| EBIT Margin | 7.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.07, which amounts to a dividend yield of 2.47%.
| Dividend Per Share | 1.07 |
| Dividend Yield | 2.47% |
| Dividend Growth (YoY) | 137.50% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 351.88% |
| Buyback Yield | 1.60% |
| Shareholder Yield | 4.17% |
| Earnings Yield | 0.49% |
| FCF Yield | -1.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 6, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 6, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |